1. Home
  2. HUDI vs AYTU Comparison

HUDI vs AYTU Comparison

Compare HUDI & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

HOLD

Current Price

$1.25

Market Cap

17.3M

Sector

Industrials

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.19

Market Cap

20.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUDI
AYTU
Founded
1998
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
20.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HUDI
AYTU
Price
$1.25
$2.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.17
AVG Volume (30 Days)
13.8K
47.6K
Earning Date
08-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,566,370.00
$63,696,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$47.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$0.95
52 Week High
$5.46
$2.82

Technical Indicators

Market Signals
Indicator
HUDI
AYTU
Relative Strength Index (RSI) 47.67 56.07
Support Level $1.23 $2.05
Resistance Level $1.34 $2.18
Average True Range (ATR) 0.07 0.12
MACD 0.01 0.02
Stochastic Oscillator 60.47 93.17

Price Performance

Historical Comparison
HUDI
AYTU

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: